Diagnosis of IDDM with a panel of immunoreagents

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 4, 436811, C12Q 100

Patent

active

052003183

ABSTRACT:
Diagnosis of insulin-dependent (Type I) diabetes mellitus (IDDM) by contacting a blood sample from a patient with an immunoreagent comprising epitopes of two or more of glutamic acid decarboxylase (GAD) and the pancreatic islet cell antigens referred to as ICA512 and ICA12. Binding of antibodies present in the blood sample with one or more of such epitopes correlates with IDDM or a potential for developing IDDM. In clinical testing, about 80 percent of sera from newly diagnosed IDDM patients react positively with at least one epitope in a GAD/ICA512 panel. Reactivity with the GAD/ICA512/ICA12 panel is between about 80 and 90 percent. The method is useful in screening patients for pre-IDDM, for distinguishing IDDM from Type II diabetes, and for monitoring therapy.

REFERENCES:
S. Baekkeskov et al., "Autoantibodies in Newly Diagnosed Diabetic Children Immunoprecipitate Human Pancreatic Islet Cell Proteins," Nature 298:167-169 (1982).
S. Baekkeskov et al., "Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase," Nature 347 151-156 (1990).
S. Baekkeskov et al., "Antibodies to a 64,000 MW Human Islet Cell Antigen Precede the Clinical Onset of Insulin-dependent Diabetes," J. Clin. Invest. 79:926-934 (1987).
M. A. Atkinson et al., "Mr. 64000 Autoantibodies (64KA) Predict Insulin Dependent Diabetes," American Diabetes Assoc. 48th Annual Meeting (1988) Abstract #391.
M. A. Atkinson et al., "64000 Mr autoantibodies as predictors of insulin-dependent diabetes," The Lancet 335:1357-1360 (1990).
Gerling, I. et al. J. of Immunol. 137:3782-3785 (1986).
Christie, M. et al, Diabetologia 31:597-602 (1988).
D. U. Rabin et al, "Cloning and Expression of IDDM-Specific Human Autoantigens" Diabetes 41:183-186 (1992).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diagnosis of IDDM with a panel of immunoreagents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnosis of IDDM with a panel of immunoreagents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis of IDDM with a panel of immunoreagents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-535833

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.